Ruthenium(II)-enabled para-selective C-H difluoromethylation of anilides and their derivatives.Transition-metal-catalyzed direct site-selective functionalization of arene C-H bonds has emerged as an innovative approach for building the core structure of pharmaceutical agents and other versatile complex compounds. 
Ruthenium(II)